Supply chain transformation in healthcare and pharma
Raheel Shah, Business Development Director at BDR Pharmaceuticals International highlights that comprehending the pivotal role of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BDR Pharmaceuticals
BDR Pharma launches BDENZA oral solution for prostate cancer
BDENZA will be available at Rs 27,000 for 150mL
BDR Pharma launches Dalbonova Injection for acute bacterial skin infections
Dalbonova offers single-dose therapy for acute bacterial skin and skin structure infections (ABSSSI) in patients of all ages,…
BDR Pharma launches generic antibiotic range medicine, Ceftazidime Avibactum
XAVITAZ is useful in treating resistant gram-negative infections, including many Ceftazidime-resistant strains
BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India
Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy…
BDR Pharma to launch 400 mg Favipiravir tablets
The 400 mg tablets will be priced at Rs 990 for a strip of 10 tablets
Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage
Many also allude to an emerging black market for remdesivir in the country through which the drug is being sold at exorbitant…
CDSCO to inspect BDR Pharma’s formulation facility, submit report in seven days
It is part of fast-tracking manufacturing and marketing applications of remdesivir, informs CDSCO
BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in…